Anna Mohammed
Papers
4
Total Citations
136
H-Index
4
About
Anna Mohammed is a leading urologic surgeon and researcher whose work centers on advancing minimally invasive surgical techniques for bladder and prostate cancers. Her major contributions focus on two key areas: optimizing outcomes in robot-assisted radical cystectomy (iRARC) and managing recurrence after focal therapy for prostate cancer. Her landmark 2017 study (76 citations) demonstrated that combining intracorporeal robot-assisted radical cystectomy with an enhanced recovery after surgery (ERAS) pathway significantly reduces hospital stays and perioperative complications, establishing a new standard of care. She has also pioneered research on salvage robotic prostatectomy following failed high-intensity focused ultrasound (HIFU) partial ablation, with her 2019 and 2020 papers (22 and 19 citations, respectively) providing critical insights into pathological recurrence patterns and the accuracy of MRI in detecting local relapse. Additionally, her 2016 work (19 citations) revealed that blood transfusion requirements—not preoperative anemia—drive complications after iRARC, challenging conventional wisdom. With over 130 total citations, Mohammed’s research has directly shaped surgical protocols and patient selection criteria, making her a recognized authority in urologic oncology and robotic surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4